CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-09 | Ling Geoffrey M.D. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2021-06-09 | LAWLOR AUGUSTINE Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2021-06-09 | Hunt Andrea Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2021-06-09 | DESOUZA ERROL B Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2021-04-05 | USMAN NASSIM President & CEO | Option exercise | +5,000 | $4.63 | $23K | 17,174 |
| 2021-04-05 | USMAN NASSIM President & CEO | Option exercise · Stock Option (Right to Buy) | −5,000 | 259,783 | ||
| 2021-04-01 | Williams Eddie Director | Grant or award | +1,215 | 18,102 | ||
| 2021-04-01 | Ling Geoffrey M.D. Director | Grant or award | +2,331 | 13,364 | ||
| 2021-04-01 | LAWLOR AUGUSTINE Director | Grant or award | +4,761 | 13,192 | ||
| 2021-04-01 | Hunt Andrea Director | Grant or award | +2,480 | 15,997 | ||
| 2021-04-01 | DESOUZA ERROL B Director | Grant or award | +2,926 | 22,807 | ||
| 2021-02-09 | USMAN NASSIM President & CEO | Purchase | +582 | $4.81 | $3K | 12,174 |
| 2021-02-09 | Levy Howard Chief Medical Officer | Purchase | +1,670 | $4.81 | $8K | 23,390 |
| 2021-02-08 | USMAN NASSIM President & CEO | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2021-02-08 | Musil Clinton Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2021-02-08 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-08 | USMAN NASSIM President & CEO | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2021-02-08 | Musil Clinton Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2021-02-08 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-01-05 | Williams Eddie Director | Grant or award | +940 | 16,887 |
Page 14 of 17 · 328 trades